The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Carbonic anhydrase 9 confers resistance to ferroptosis/apoptosis in malignant mesothelioma under hypoxia
Open accessAbstract
Hypoxia and acidity provide microenvironment for selection under evolutionary pressure and proliferation in cancer cells. Carbonic anhydrases (CAs) are a superfamily of metalloenzymes present in all life kingdoms, equilibrating the reactions among CO2, bicarbonate and H+. CA9, a membrane-associated α-CA, has been a drug target for various cancers. Whereas iron is essential not only for cancer cells but also for all the lives on earth, little is known on the association among hypoxia, iron metabolism, extracellular acidity and redox regulation. Malignant mesothelioma (MM), an aggressive tumor with poor prognosis, is an intriguing model in that asbestos-associated pathogenesis includes excess iron environment during carcinogenesis. Re-analysis of rat asbestos-induced MM model revealed an inverse association between high CA9 expression and survival. Here we used human MMs to identify the molecular events surrounding CA9 from the viewpoint of iron metabolism. CA9 expression was significantly higher in MM cells than in MeT-5A mesothelial cells, which was further amplified under hypoxia (1%O2) with increased catalytic Fe(II). CA9 suppression by inhibitors (S4 and U104) decreased viability and migration of MM cells, accompanied by overexpression of TFRC, IREB1/2 and FPN1(SLC40A1) and by downregulation of FTH/FTL. This expressional pattern was similar to that of erastin-induced ferroptosis in the same cells. Furthermore, we observed mitochondrial fission and enhanced autophagy with increased catalytic Fe(II) in both mitochondria and lysosomes after CA9 inhibition, accompanied by increased peroxides, mitochondrial O2− and lipid peroxidation. The eventual cell death was significantly inhibited by deferoxamine, ferrostatin-1 and Z-VAD-FMK, suggesting a mixed cell death of ferroptosis and apoptosis. Therefore, CA9 plays a role in equilibrating among hypoxia, iron metabolism and redox regulation in MM cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease
Stockwell, B. R., Friedmann Angeli, J. P., Bayir, H., Bush, A. I., Conrad, M., Dixon, S. J., Fulda, S., Gascón, S., Hatzios, S. K., Kagan, V. E., et al. (2017) · Cell · doi:10.1016/j.cell.2017.09.021 · Cited by 7,695
Self-citationGalluzzi, L., Vitale, I., Aaronson, S. A., Abrams, J. M., Adam, D., Agostinis, P., Alnemri, E. S., Altucci, L., Amelio, I., Andrews, D. W., et al. (2018) · Cell Death & Differentiation · doi:10.1038/s41418-017-0012-4 · Cited by 6,680
Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden
Chalmers, Z. R., Connelly, C. F., Fabrizio, D., Gay, L., Ali, S. M., Ennis, R., Schrock, A., Campbell, B., Shlien, A., Chmielecki, J., et al. (2017) · Genome Medicine · doi:10.1186/s13073-017-0424-2 · Cited by 3,519
Autophagy promotes ferroptosis by degradation of ferritin
Hou, W., Xie, Y., Song, X., Sun, X., Lotze, M. T., Zeh, H. J., Kang, R., & Tang, D. (2016) · Autophagy · doi:10.1080/15548627.2016.1187366 · Cited by 2,332
Hypoxia-Inducible Factors: Master Regulators of Cancer Progression
Schito, L., & Semenza, G. L. (2016) · Trends in Cancer · doi:10.1016/j.trecan.2016.10.016 · Cited by 962
Hypoxia and Metabolic Adaptation of Cancer Cells
Eales, K. L., Hollinshead, K. E. R., & Tennant, D. A. (2016) · Oncogenesis · doi:10.1038/oncsis.2015.50 · Cited by 724 · cited 1×
“Furthermore, recent studies suggest that hypoxia promotes cancer cells to acquire aggressive phenotypes through reprogramming iron metabolism for more iron acquisition and retention [30,31].”
BackgroundDrakesmith, H., Nemeth, E., & Ganz, T. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.09.006 · Cited by 638
Role of iron in carcinogenesis: cancer as a ferrotoxic disease
Toyokuni, S. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2008.01001.x · Cited by 552
Self-citationHypoxia-inducible factors link iron homeostasis and erythropoiesis
Shah, Y. M., & Xie, L. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.12.031 · Cited by 187
Iron overload signature in chrysotile-induced malignant mesothelioma
Jiang, L., Akatsuka, S., Nagai, H., Chew, S., Ohara, H., Okazaki, Y., Yamashita, Y., Yoshikawa, Y., Yasui, H., Ikuta, K., et al. (2012) · The Journal of Pathology · doi:10.1002/path.4075 · Cited by 104
Research works printed but not linked: 55
- Bray, 2018, Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA A Cancer J. Clin., 68, 394
- Logozzi, 2019, Prostate cancer cells and exosomes in acidic condition show increased carbonic anhydrase IX expression and activity, J. Enzym. Inhib. Med. Chem., 34, 272, 10.1080/14756366.2018.1538980 · DOI
- Robinson, 2005, Advances in malignant mesothelioma, N. Engl. J. Med., 353, 1591, 10.1056/NEJMra050152 · DOI · Paper page
- Chew, 2015, Malignant mesothelioma as an oxidative stress-induced cancer: an update, Free Radic. Biol. Med., 86, 166, 10.1016/j.freeradbiomed.2015.05.002 · DOI · Paper page
- Toyokuni, 2017, Iron and thiol redox signaling in cancer: an exquisite balance to escape ferroptosis, Free Radic. Biol. Med., 108, 610, 10.1016/j.freeradbiomed.2017.04.024 · DOI · Paper page
- Toyokuni, 2009, Mechanisms of asbestos-induced carcinogenesis, Nagoya J. Med. Sci., 71, 1
- Scherpereel, 2018, Novel therapies for malignant pleural mesothelioma, Lancet Oncol., 19, e161, 10.1016/S1470-2045(18)30100-1 · DOI
- Renvall, 1980, Kinetics of oxygen in peritoneal cavity. Effects of chemical peritonitis and intraperitoneally administered colloids in rats, J. Surg. Res., 28, 132, 10.1016/0022-4804(80)90156-0 · doi:10.1016/0022-4804(80)90156-0
- Nabavi, 2016, Switching off malignant mesothelioma: exploiting the hypoxic microenvironment, Genes Cancer, 7, 340
- Kim, 2018, Hypoxia promotes acquisition of aggressive phenotypes in human malignant mesothelioma, BMC Canc., 18, 819, 10.1186/s12885-018-4720-z · DOI · Paper page
- Mujoomdar, 2010, Prevalence of in vitro chemotherapeutic drug resistance in primary malignant pleural mesothelioma: result in a cohort of 203 resection specimens, J. Thorac. Cardiovasc. Surg., 140, 352, 10.1016/j.jtcvs.2009.11.072 · DOI
- Kilic, 2007, Role of hypoxia inducible factor-1 alpha in modulation of apoptosis resistance, Oncogene, 26, 2027, 10.1038/sj.onc.1210008 · DOI · Paper page
- Fulda, 2007, HIF-1-regulated glucose metabolism: a key to apoptosis resistance?, Cell Cycle, 6, 790, 10.4161/cc.6.7.4084 · DOI
- Tacchini, 1999, Transferrin receptor induction by hypoxia. HIF-1-mediated transcriptional activation and cell-specific post-transcriptional regulation, J. Biol. Chem., 274, 24142, 10.1074/jbc.274.34.24142 · DOI · Paper page
- Qian, 2011, Divalent metal transporter 1 is a hypoxia-inducible gene, J. Cell. Physiol., 226, 1596, 10.1002/jcp.22485 · DOI
- Yanatori, 2019, DMT1 and iron transport, Free Radic. Biol. Med., 133, 55, 10.1016/j.freeradbiomed.2018.07.020 · DOI · Paper page
- Huang, 2014, Distinct regulatory mechanisms of the human ferritin gene by hypoxia and hypoxia mimetic cobalt chloride at the transcriptional and post-transcriptional levels, Cell. Signal., 26, 2702, 10.1016/j.cellsig.2014.08.018 · DOI
- Hanson, 1999, Hypoxia post-translationally activates iron-regulatory protein 2, J. Biol. Chem., 274, 5047, 10.1074/jbc.274.8.5047 · DOI
- Torti, 2013, Iron and cancer: more ore to be mined, Nat. Rev. Cancer, 13, 342, 10.1038/nrc3495 · DOI · Paper page
- Supuran, 2018, Carbonic Anhydrases and Metabolism, Metabolites, 8, 25, 10.3390/metabo8020025 · DOI · Paper page
- Banerjee, 2016, On origin and evolution of carbonic anhydrase isozymes: a phylogenetic analysis from whole-enzyme to active site, Comput. Biol. Chem., 61, 121, 10.1016/j.compbiolchem.2016.01.003 · doi:10.1016/j.compbiolchem.2016.01.003
- Supuran, 2008, Carbonic anhydrases: novel therapeutic applications for inhibitors and activators, Nat. Rev. Drug Discov., 7, 168, 10.1038/nrd2467 · DOI · Paper page
- Wykoff, 2000, Hypoxia-inducible expression of tumor-associated carbonic anhydrases, Cancer Res., 60, 7075
- Chiche, 2009, Hypoxia-inducible carbonic anhydrase IX and XII promote tumor cell growth by counteracting acidosis through the regulation of the intracellular pH, Cancer Res., 69, 358, 10.1158/0008-5472.CAN-08-2470 · DOI · Paper page
- Mboge, 2018, Carbonic anhydrases: role in pH control and cancer, Metabolites, 8, 19, 10.3390/metabo8010019 · DOI · Paper page
- Ryder, 2012, Acidosis promotes Bcl-2 family-mediated evasion of apoptosis: involvement of acid-sensing G protein-coupled receptor Gpr65 signaling to Mek/Erk, J. Biol. Chem., 287, 27863, 10.1074/jbc.M112.384685 · DOI
- Swayampakula, 2017, The interactome of metabolic enzyme carbonic anhydrase IX reveals novel roles in tumor cell migration and invadopodia/MMP14-mediated invasion, Oncogene, 36, 6244, 10.1038/onc.2017.219 · DOI · Paper page
- Shin, 2011, Carbonic anhydrase IX (CA9) modulates tumor-associated cell migration and invasion, J. Cell Sci., 124, 1077, 10.1242/jcs.072207 · DOI
- Chafe, 2019, Targeting hypoxia-induced carbonic anhydrase IX enhances immune-checkpoint blockade locally and systemically, Cancer Immunol. Res., 7, 1064, 10.1158/2326-6066.CIR-18-0657 · DOI · Paper page
- Casalone, 2018, DNA methylation profiling of asbestos-treated MeT5A cell line reveals novel pathways implicated in asbestos response, Arch. Toxicol., 92, 1785, 10.1007/s00204-018-2179-y · DOI
- Usami, 2006, Establishment and characterization of four malignant pleural mesothelioma cell lines from Japanese patients, Cancer Sci., 97, 387, 10.1111/j.1349-7006.2006.00184.x · DOI
- Rao, 2013, An improvement of the 2∧(-delta delta CT) method for quantitative real-time polymerase chain reaction data analysis, Biostat. Bioinforma. Biomath., 3, 71
- Chew, 2017, Rheostatic CD44 isoform expression and its association with oxidative stress in human malignant mesothelioma, Free Radic. Biol. Med., 106, 91, 10.1016/j.freeradbiomed.2017.02.011 · DOI
- Hirayama, 2017, A universal fluorogenic switch for Fe(ii) ion based on N-oxide chemistry permits the visualization of intracellular redox equilibrium shift towards labile iron in hypoxic tumor cells, Chem. Sci., 8, 4858, 10.1039/C6SC05457A · DOI · Paper page
- Toyokuni, 1989, Cirrhosis of the liver induced by cupric nitrilotriacetate in Wistar rats. An experimental model of copper toxicosis, Am. J. Pathol., 134, 1263
- Valente, 2017, A simple ImageJ macro tool for analyzing mitochondrial network morphology in mammalian cell culture, Acta Histochem., 119, 315, 10.1016/j.acthis.2017.03.001 · DOI · Paper page
- Koukourakis, 2001, Hypoxia-regulated carbonic anhydrase-9 (CA9) relates to poor vascularization and resistance of squamous cell head and neck cancer to chemoradiotherapy, Clin. Cancer Res., 7, 3399
- Wouters, 1997, Cells at intermediate oxygen levels can be more important than the "hypoxic fraction" in determining tumor response to fractionated radiotherapy, Radiat. Res., 147, 541, 10.2307/3579620 · DOI · Paper page
- Lou, 2011, Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors, Cancer Res., 71, 3364, 10.1158/0008-5472.CAN-10-4261 · DOI · Paper page
- Hektoen, 2016, Sulfamate inhibitor S4 influences carbonic anhydrase IX ectodomain shedding in colorectal carcinoma cells, J. Enzym. Inhib. Med. Chem., 31, 779, 10.3109/14756366.2015.1069286 · DOI
- Svastova, 2012, Carbonic anhydrase IX interacts with bicarbonate transporters in lamellipodia and increases cell migration via its catalytic domain, J. Biol. Chem., 287, 3392, 10.1074/jbc.M111.286062 · DOI · Paper page
- Gao, 2016, Ferroptosis is an autophagic cell death process, Cell Res., 26, 1021, 10.1038/cr.2016.95 · DOI · Paper page
- Dixon, 2012, Ferroptosis: an iron-dependent form of nonapoptotic cell death, Cell, 149, 1060, 10.1016/j.cell.2012.03.042 · DOI · Paper page
- van der Bliek, 2013, Mechanisms of mitochondrial fission and fusion, Cold Spring Harb. Perspect. Biol., 5, a011072, 10.1101/cshperspect.a011072 · DOI · Paper page
- Toyokuni, 1996, Iron-induced carcinogenesis: the role of redox regulation, Free Radic. Biol. Med., 20, 553, 10.1016/0891-5849(95)02111-6 · DOI · Paper page
- Nyholm, 1993, Role of ribonucleotide reductase in inhibition of mammalian cell growth by potent iron chelators, J. Biol. Chem., 268, 26200, 10.1016/S0021-9258(19)74300-2 · DOI · Paper page
- Olson, 2016, The role of hydrogen sulfide in evolution and the evolution of hydrogen sulfide in metabolism and signaling, Physiology, 31, 60, 10.1152/physiol.00024.2015 · DOI · Paper page
- Mukaide, 2014, Histological detection of catalytic ferrous iron with the selective turn-on fluorescent probe RhoNox-1 in a Fenton reaction-based rat renal carcinogenesis model, Free Radic. Res., 48, 990, 10.3109/10715762.2014.898844 · DOI
- Hirayama, 2017, Chemical tools for detecting Fe ions, J. Clin. Biochem. Nutr., 60, 39, 10.3164/jcbn.16-70 · DOI
- Liuzzi, 2006, Zip 14 (Slc39a14) mediates non-transferrin-bound iron uptake into cells, Proc. Natl. Acad. Sci. U. S. A., 103, 13612, 10.1073/pnas.0606424103 · DOI · Paper page
- Tandy, 2000, Nramp2 expression is associated with pH-dependent iron uptake across the apical membrane of human intestinal Caco-2 cells, J. Biol. Chem., 275, 1023, 10.1074/jbc.275.2.1023 · DOI · Paper page
- Razi, 2009, Early endosomes and endosomal coatomer are required for autophagy, J. Cell Biol., 185, 305, 10.1083/jcb.200810098 · DOI · Paper page
- Ikeda, 2015, Endogenous Drp1 mediates mitochondrial autophagy and protects the heart against energy stress, Circ. Res., 116, 264, 10.1161/CIRCRESAHA.116.303356 · DOI · Paper page
- Zheng, 2018, Iron overload promotes mitochondrial fragmentation in mesenchymal stromal cells from myelodysplastic syndrome patients through activation of the AMPK/MFF/Drp1 pathway, Cell Death Dis., 9, 515, 10.1038/s41419-018-0552-7 · DOI
- Fossati, 2016, The carbonic anhydrase inhibitor methazolamide prevents amyloid beta-induced mitochondrial dysfunction and caspase activation protecting neuronal and glial cells in vitro and in the mouse brain, Neurobiol. Dis., 86, 29, 10.1016/j.nbd.2015.11.006 · DOI
Cited by
Ferroptosis: molecular mechanisms and health implications
Tang, D., Chen, X., Kang, R., & Kroemer, G. (2021) · Cell Research · doi:10.1038/s41422-020-00441-1 · Cited by 4,256
The crosstalk between ferroptosis and mitochondrial dynamic regulatory networks
Li, J., Jia, Y.-C., Ding, Y.-X., Bai, J., Cao, F., & Li, F. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.83348 · Cited by 383
Emerging mechanisms and targeted therapy of ferroptosis in cancer
Wang, H., Cheng, Y., Mao, C., Liu, S., Xiao, D., Huang, J., & Tao, Y. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.03.022 · Cited by 312
The function and mechanism of ferroptosis in cancer
Wang, Y., Wei, Z., Pan, K., Li, J., & Chen, Q. (2020) · Apoptosis · doi:10.1007/s10495-020-01638-w · Cited by 263
Ferroptosis at the crossroads of infection, aging and cancer
Toyokuni, S., Yanatori, I., Kong, Y., Zheng, H., Motooka, Y., & Jiang, L. (2020) · Cancer Science · doi:10.1111/cas.14496 · Cited by 142
Self-citation
Metadata
- Authors
- Li, Z., Jiang, L., Chew, S. H., Hirayama, T., Sekido, Y., & Toyokuni, S.
- Venue
- Redox Biology
- Publisher
- Elsevier BV
- Published
- 2019-09
- Volume
- 26
- Pages
- 101297
- ISSN
- 2213-2317 (ISSN-L)
- OpenAlex
- W2968612009
- Cited by
- 163
- References
- 20
- FWCI
- 4.58
- Type
- journal article
- Language
- en
- Open access
- gold
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
- Funders
- Japan Society for the Promotion of Science (JP17H04064, JP19H05462)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Carbonic anhydrase 9 confers resistance to ferroptosis/apoptosis in malignant mesothelioma under hypoxia. https://app.cochat.ai/papers/10.1016/j.redox.2019.101297
- The paper
- Li, Z., Jiang, L., Chew, S. H., Hirayama, T., Sekido, Y., & Toyokuni, S. (2019). Carbonic anhydrase 9 confers resistance to ferroptosis/apoptosis in malignant mesothelioma under hypoxia. Redox Biology. https://doi.org/10.1016/j.redox.2019.101297
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.